MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Sex-Stratified Multi-Omic Integration Identifies Sexually Dimorphic Molecular Targets in Parkinson’s Disease

    J-Y. Lee, J. Lee, S. Lee, JH. Yoon, DG. Park, J. Sung (Seoul, Republic of Korea)

    Objective: To identify sex-specific causal proteins and biological pathways underlying the sexual dimorphism of Parkinson's disease (PD) through an integrative multi-omics framework. Background: PD exhibits…
  • 2026 International Congress

    Evaluation of Sleep Parameters in Parkinson’s Disease According to Disease Duration Using Ambulatory Circadian Monitoring

    L. Núñez Santos, MF. Valero García, B. Vives Pastor, M. Sastre Mesquida, A. Colomé Menoyo, S. Ferrández Sempere, E. Bargay Pizarro, C. Vallés Serrano, I. Legarda Ramírez (Palma, Spain)

    Objective: To evaluate clinical characteristics and objective sleep parameters in patients with Parkinson’s disease (PD) according to disease duration (<6 years versus >6 years). Background: Sleep disturbances are…
  • 2026 International Congress

    Restoring Dopaminergic Function: iPSC-derived MSCs Show Therapeutic Promise in Parkinson’s Disease Rat Model

    U. Gogoi, R. Ghanty, N. Kamble, V. Holla, R. Yadav, P. Pal, I. Datta (Bengaluru, India)

    Objective: This study looked into the therapeutic potential of human induced pluripotent stem cell derived mesenchymal stromal cells (iMSCs) in a MPTP induced Parkinson’s disease rat model. Background: PD…
  • 2026 International Congress

    Levodopa-Induced Dyskinesias in Patients with Parkinson’s Disease in the Uzbek Population

    G. Isroilova, Z. Sayfitdinkhuzhaev (Tashkent, Uzbekistan)

    Objective: To investigate the clinical features and prevalence of levodopa-induced dyskinesias in patients with Parkinson’s disease in the Uzbek population. Background: Levodopa-induced dyskinesias (LID) are…
  • 2026 International Congress

    From Vision to Reality: Nursing Driven Implementation, Policy, and Safety Framework for Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in a Tertiary Movement Disorder Centre

    E. de Freitas, S. Mittal (Abu Dhabi, United Arab Emirates)

    Objective: To describe the development of nursing roles, policies, and safety processes supporting implementation of foslevodopa/foscarbidopa infusion therapy for advanced Parkinson’s disease in a tertiary…
  • 2026 International Congress

    Muscarinic receptor antagonism beyond M4 is required for efficacy in a preclinical model of dystonia and Parkinson’s disease

    M. Rogge, J. Thornton, T. Engber, S. Engel, J. Dunn (Cambridge, USA)

    Objective: To inform the target activity profile of future movement disorder therapies, pre-clinical studies quantified the contribution of M4 receptor occupancy (M4RO) to reversal of…
  • 2026 International Congress

    Normative Data for the IDEA Dementia Screen in Healthy Older Adults and People with Parkinson’s Disease in Ethiopia: A Comparative Cross Sectional Study

    S. Gugssa, H. Kiflu, Y. Okkaoglu, G. Mengistu (Addis Ababa, Ethiopia)

    Objective: This study aims to establish Ethiopian normative data for IDEA in healthy older adults and People with Parkinson's disease, and to evaluate its appropriateness…
  • 2026 International Congress

    Wearable assessment of levodopa-entacapone-carbidopa intestinal gel treatment characteristics at home: Pilot Protocol

    J. Gerstl, H. Widner (Lund, Sweden)

    Objective: To determine whether symptom profiles of levodopa-entacapone-carbidopa intestinal gel therapy can be effectively captured using continuous smartwatch-based monitoring compared to patient diaries and clinical…
  • 2026 International Congress

    QSM-Based Substantia Nigra Volumetry Improves Differentiation of Progressive Supranuclear Palsy from Parkinson’s Disease and Multiple System Atrophy

    S. Chung, S. Jo, H. Candan, M. Choi, G. Lee, E. Lee, H. Cho (Seoul, Republic of Korea)

    Objective: To evaluate whether quantitative susceptibility mapping (QSM)-based substantia nigra (SN) volumetry improves differentiation of progressive supranuclear palsy (PSP) from Parkinson’s disease (PD) and multiple…
  • 2026 International Congress

    Automated CRST Spiral Drawing Scoring Using a Multimodal Vision-language model: Development and Validation in a Large Essential Tremor Cohort

    C. Reddy, A. Zoana, M. Lotia, N. Reddy, A. Ahmed, J. Ledoux, P. Nonat, R. Guevarra (Celebration, USA)

    Objective: The Clinical Rating Scale for Tremor (CRST) is widely adopted for quantifying upper extremity tremor severity in essential tremor (ET), yet manual scoring remains…
  • « Previous Page
  • 1
  • …
  • 135
  • 136
  • 137
  • 138
  • 139
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley